Literature DB >> 15539721

Incidence and risk factors of delayed pneumothorax after transthoracic needle biopsy of the lung.

Chang-Min Choi1, Sang-Won Um, Chul-Gyu Yoo, Young Whan Kim, Sung Koo Han, Young-Soo Shim, Choon-Taek Lee.   

Abstract

STUDY
OBJECTIVES: To evaluate the incidence and clinical significance of delayed pneumothorax, and to analyze the influence of multiple variables on the rate of delayed pneumothorax associated with transthoracic needle biopsy (TTNB) of the lung. STUDY
DESIGN: Prospective study.
SETTING: Tertiary care university hospital. STUDY
SUBJECTS: Adult patients underwent TTNB from June 2001 to June 2002. MEASUREMENTS AND
RESULTS: Among the 458 patients included in this study, 280 fluoroscopic-guided, 21 CT-guided, and 157 ultrasonography-guided lung biopsies were performed. A follow-up chest radiograph was obtained immediately, and 3 h, 8 h, and 24 h after the biopsy procedure. Pneumothorax that had not developed up to 3 h but developed later was defined as a delayed pneumothorax. Patients with a symptomatic or enlarged pneumothorax were treated using a pigtail catheter or chest tube. Variables such as age, gender, lesion size, location, presence of an emphysematous change, biopsy guidance methods, and biopsy devices were analyzed. Pneumothorax developed in 100 of the 458 patients (21.8%), and delayed pneumothorax developed in 15 patients (3.3%). Seventeen patients, including 3 patients with delayed pneumothorax, required a pigtail catheter or a chest tube insertion. The pigtail catheter or chest tube insertion rate in delayed pneumothorax was 20% (3 of 15 patients). Female gender and the absence of an emphysematous change correlated with an increased rate of delayed pneumothorax (p < 0.05). Lesion size, location, biopsy guidance methods, devices, and underlying diseases were not correlated with the delayed pneumothorax rate.
CONCLUSIONS: The incidence of delayed pneumothorax was 3.3% of all TTNBs. Female gender and the absence of an emphysematous change were identified as risk factors for delayed pneumothorax. Delayed pneumothorax is clinically important because of its considerable incidence and the necessity for pigtail catheterization or chest tube insertion in these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15539721     DOI: 10.1378/chest.126.5.1516

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Transthoracic needle biopsy.

Authors:  Katherine R Birchard
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 2.  Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance.

Authors:  Tatjana Boskovic; Jelena Stanic; Slobodanka Pena-Karan; Paul Zarogoulidis; Kostas Drevelegas; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Andreas Mpakas; Kosmas Tsakiridis; Georgios Kesisis; Theodora Tsiouda; Ioanna Kougioumtzi; Stamatis Arikas; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

3.  The results of computed tomography guided tru-cut transthoracic biopsy: complications and related risk factors.

Authors:  Fahri Halit Beşir; Remzi Altın; Levent Kart; Muhammed Akkoyunlu; Hüseyin Ozdemir; Tacettin Ornek; Sadi Gündoğdu
Journal:  Wien Klin Wochenschr       Date:  2011-02-17       Impact factor: 1.704

4.  CT-guided lung biopsy: incidence of pneumothorax after instillation of NaCl into the biopsy track.

Authors:  Christian Billich; Rainer Muche; Gerhard Brenner; Stefan A Schmidt; Stefan Krüger; Hans-Jürgen Brambs; Sandra Pauls
Journal:  Eur Radiol       Date:  2008-02-13       Impact factor: 5.315

Review 5.  Transthoracic needle aspiration: the past, present and future.

Authors:  Arun Chockalingam; Kelvin Hong
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

6.  Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity 18 F-FDG injection.

Authors:  Assen S Kirov; Louise M Fanchon; Daniel Seiter; Christian Czmielewski; James Russell; Snjezana Dogan; Sean Carlin; Katja Pinker-Domenig; Ellen Yorke; C Ross Schmidtlein; Vitaly Boyko; Sho Fujisawa; Katia Manova-Todorova; Pat Zanzonico; Lawrence Dauer; Joseph O Deasy; John L Humm; Stephen Solomon
Journal:  Med Phys       Date:  2018-03-23       Impact factor: 4.071

7.  Time-dependent analysis of incidence, risk factors and clinical significance of pneumothorax after percutaneous lung biopsy.

Authors:  Woo Hyeon Lim; Chang Min Park; Soon Ho Yoon; Hyun-Ju Lim; Eui Jin Hwang; Jong Hyuk Lee; Jin Mo Goo
Journal:  Eur Radiol       Date:  2017-10-02       Impact factor: 5.315

8.  Role of CT-guided percutaneous lung biopsy in diagnosis of pulmonary fungal infection in patients with hematologic diseases.

Authors:  Ji-Min Shi; Zhen Cai; He Huang; Xiu-Jin Ye; Jing-Song He; Wan-Zhuo Xie; Jie Zhang; Xian-Yong Zhou; Yi Luo; Yu Lin; Li Li; Wei-Yan Zheng; Guo-Qing Wei; Mao-Fang Lin
Journal:  Int J Hematol       Date:  2009-05-27       Impact factor: 2.490

9.  Do bullae and emphysema increase risk of pneumothorax in silicosis?

Authors:  Iraj Mohebbi; Ebrahim Hassani; Shaker Salarilak; Abdul Rahman Bahrami
Journal:  Indian J Occup Environ Med       Date:  2007-09

10.  Chest computed tomography (CT) immediately after CT-guided transthoracic needle aspiration biopsy as a predictor of overt pneumothorax.

Authors:  Tae June Noh; Chang Hoon Lee; Young Ae Kang; Sung-Youn Kwon; Ho-Il Yoon; Tae Jung Kim; Kyung Won Lee; Jae Ho Lee; Choon-Taek Lee
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.